Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 27;4(2):55.
doi: 10.3390/tropicalmed4020055.

The As and Bs of HIV and Hepatitis Co-Infection

Affiliations
Review

The As and Bs of HIV and Hepatitis Co-Infection

Darcy Wooten et al. Trop Med Infect Dis. .

Abstract

Hepatitis A and B co-infection among people living with HIV are public health challenges that account for an increasing degree of morbidity and mortality. Understanding the changing epidemiology, clinical manifestations, and new approaches to treatment and prevention continues to be important in the care of people living with HIV. We conducted a review of the literature that included studies on hepatitis A and HIV co-infection and hepatitis B and HIV co-infection, focusing on epidemiology, clinical manifestations, treatment, and prevention. Important updates include the changing epidemiology of hepatitis A outbreaks among the homeless and individuals who use substances, and novel approaches to hepatitis B vaccination and hepatitis B cure strategies.

Keywords: HIV; co-infection; hepatitis A; hepatitis B.

PubMed Disclaimer

Conflict of interest statement

MK receives research funding to the institution from Gilead Sciences and ViiV Healthcare and has served on an advisory board for Gilead Sciences.

Figures

Figure 1
Figure 1
Algorithm of the evaluation and prevention and treatment strategies for hepatitis B virus infection in people living with HIV.

Similar articles

Cited by

References

    1. Lin K.Y., Chen G.J., Lee Y.L., Huang Y.C., Cheng A., Sun H.Y., Chang S.Y., Liu C.E., Hung C.C. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review. World J. Gastroenterol. 2017;23:3589–3606. doi: 10.3748/wjg.v23.i20.3589. - DOI - PMC - PubMed
    1. Spada E., Genovese D., Tosti M.E., Mariano A., Cuccuini M., Proietti L., Giuli C.D., Lavagna A., Crapa G.E., Morace G., et al. An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users. J. Hepatol. 2005;43:958–964. doi: 10.1016/j.jhep.2005.06.012. - DOI - PubMed
    1. Foster M., Ramachandran S., Myatt K., Donovan D., Bohm S., Fiedler J., Barbeau B., Collins J., Thoroughman D., McDonald E., et al. Hepatitis A Virus Outbreaks Associated with Drug Use and Homelessness—California, Kentucky, Michigan, and Utah, 2017. Morb. Mortal. Wkly. Rep. 2018;67:1208–1210. doi: 10.15585/mmwr.mm6743a3. - DOI - PMC - PubMed
    1. Lin K.Y., Hsieh S.M., Sun H.Y., Lo Y.C., Sheng W.H., Chuang Y.C., Cheng A., Pan S.C., Chen G.J., Hung C.C., et al. Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus-positive individuals during the outbreak of acute hepatitis A. Hepatology. 2018;68:22–31. doi: 10.1002/hep.29780. - DOI - PubMed
    1. Kourkounti S., Papaizos V., Leuow K., Kordosis T., Antoniou C. Hepatitis A vaccination and immunological parameters in HIV-infected patients. Viral. Immunol. 2013;26:357–363. doi: 10.1089/vim.2012.0100. - DOI - PubMed